Caxton Associates (New York)’s Avantax, Inc. Common Stock AVTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-15,900
Closed -$402K 564
2017
Q3
$402K Sell
15,900
-600
-4% -$13.6K 0.01% 400
2017
Q2
$350K Buy
16,500
+2,600
+19% +$51.5K 0.01% 428
2017
Q1
$240K Buy
+13,900
New +$218K ﹤0.01% 366

Other funds holding AVTA

Caxton Associates (New York)'s AVTA Position: Q4 2017 in Review

Caxton Associates (New York) sold out of Avantax, Inc. Common Stock (AVTA) in Q4 2017, closing a stake of 15,900 shares — an estimated $402K sold.

Caxton Associates (New York) first reported a position in AVTA in Q1 2017 and held it in 3 quarters. The position peaked at $402K in Q3 2017. 187 funds tracked by Wall St. Rank hold AVTA as of Q4 2017.

  • Caxton Associates (New York) reported no remaining Avantax, Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
  • Caxton Associates (New York) sold 15,900 Avantax, Inc. Common Stock shares in Q4 2017, an estimated $402K.
  • Caxton Associates (New York) first reported a position in Avantax, Inc. Common Stock in Q1 2017 and held it in 3 quarters.
  • Caxton Associates (New York)'s Avantax, Inc. Common Stock position peaked at $402K in Q3 2017.
  • 187 funds tracked by Wall St. Rank held Avantax, Inc. Common Stock as of Q4 2017.

Based on Caxton Associates (New York)'s 13F filing for Q4 2017, filed 14 Feb 2018.